SAN FRANCISCO, Sept. 15, 2025 /PRNewswire/ — MedSetGo, an AI-driven healthcare company modernizing patient care transitions, today announced the close of its $2.4 million oversubscribed seed round, exceeding its target by 20%. The round was led by TurboStart with participation from Gold House Ventures, which also invested in MedSetGo’s pre-seed round, as well as a series of high profile angel investors.

“The post-acute care ecosystem in the US is broken—held together by fax machines and phone calls. MedSetGo is solving this with deep empathy, strong product thinking, and a real-world understanding of the care journey. Their traction across hospitals, health plans, and service providers gives us confidence that they’re building not just a tool, but critical infrastructure,” said Ganesh Raju, Founder of TurboStart.

The new funding will accelerate product development and hiring, with a focus on expanding its engineering, data science, and commercialization teams.

“Healthcare is long overdue for innovation, and AI gives us the opportunity to redesign how patients move across the system. At MedSetGo, we’re focused on being a true healthcare partner—streamlining the process of finding and scheduling the right care after discharge. TurboStart and Gold House Ventures have been incredible partners on this journey, and we’re deeply grateful to all our investors and advisors who believe in our mission to modernize care transitions,” said Shrey Kapoor, Founder & CEO of MedSetGo.

About MedSetGo
MedSetGo is a healthcare technology company leveraging artificial intelligence to reduce clinician burden, improve efficiency, and enhance patient outcomes. For more information, visit https://medsetgo.ai/

Contact: 
Shrey Kapoor 
shrey@medsetgo.ai

SOURCE MedSetGo

Copyright © 2025 Cision US Inc.